Agenda
DAY 1
DAY 2
Session II
HER2+, Continued
Friday, September 18, 2026
4:25 pm
—
5:50 pm
Credits Available
View Full Attendance Credit
Session Moderator(s)
PRESENTATIONS IN THIS SESSION
Session Introduction
Transforming Outcomes in Metastatic HER2-Postive Breast Cancer
CNS Metastases in HER2-Positive Breast Cancer: Closing the Therapeutic Gap
Manmeet Ahluwalia, MD, MBA, FASCO
The Balancing Act: Endocrine Meets HER2 in Triple-Positive Disease
Audience Q&A and Panel Discussion
Reshma L. Mahtani, DO; Manmeet Ahluwalia, MD, MBA, FASCO; Nan Chen, MD; Abi Siva, MD


